(Q33911973)

30 July 2017

1 reference

title

Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast? (English)

1 reference

30 July 2017

1 reference

K Zaugg

1

1 reference

30 July 2017

S Bodis

series ordinal

2

1 reference

30 July 2017

language of work or name

1 reference

1 May 2000

1 reference

Radiotherapy and Oncology

30 July 2017

published in

1 reference

30 July 2017

volume

55

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

95-99

1 reference

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Extensive apoptosis in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Incidence of and treatment for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

1 reference

7 January 2021

Management of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Apoptosis in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

p53 mutations in benign breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Ductal carcinoma in situ (intraductal carcinoma) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Cyclin D1 provides a link between development and oncogenesis in the retina and breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

bcl-2 expression in the spectrum of preinvasive breast lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Cyclins and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Animal models for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

Immunohistochemistry of cyclin D1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900186-3

7 January 2021

10.1016/S0167-8140(99)00186-3

Identifiers

DOI

1 reference

30 July 2017

1 reference